TorreyPines Therapeutics
La Jolla
About TorreyPines Therapeutics
TorreyPines Therapeutics engages in the discovery and development of small molecule compounds in the United States. Its product portfolio includes both candidates from its drug targeting platforms and in-licensed and acquired product candidates. As of August 31, 2010, its pipeline includes three clinical development programs. It also has three other clinical-stage product candidates, for which it is seeking business development partners, and it has four preclinical product candidates it is developing, three of which are based upon its drug-targeting platforms.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $81.3M
- Funding stage: M&A
- Last round: Series C (Jul 2006)
- Website: torreypinestherapeutics.com
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Canonical: https://fsome.com/organization/torreypines-therapeutics-2433585 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.